TLDR Senate Banking Committee members remain optimistic about advancing the crypto bill despite recent delays and setbacks. Coinbase CEO Brian Armstrong withdrewTLDR Senate Banking Committee members remain optimistic about advancing the crypto bill despite recent delays and setbacks. Coinbase CEO Brian Armstrong withdrew

Senate Banking Committee Lawmakers Optimistic About Crypto Bill Progress

TLDR

  • Senate Banking Committee members remain optimistic about advancing the crypto bill despite recent delays and setbacks.
  • Coinbase CEO Brian Armstrong withdrew support for the bill over concerns about stablecoin returns and SEC authority.
  • Lawmakers, including Sen. Cynthia Lummis, remain confident that a bipartisan agreement is within reach.
  • The crypto industry continues to support the bill, urging lawmakers not to abandon efforts for regulatory clarity.
  • The Senate Agriculture Committee’s rescheduled hearing will add more time to build bipartisan support for the bill.

Lawmakers are determined to move forward with the crypto bill, despite recent delays and setbacks. The Senate Banking Committee had planned to discuss a sweeping crypto bill on Thursday, but Coinbase CEO Brian Armstrong withdrew support. The delay occurred after Armstrong raised concerns about stablecoin returns and SEC authority, prompting committee Chair Tim Scott to postpone the hearing.

Lawmakers Stay Optimistic About Advancing Crypto Bill

Although the Senate Banking Committee postponed the hearing, several committee members remain optimistic. Sen. Cynthia Lummis, R-Wyo., assured on social media that lawmakers are “closer than ever” to reaching an agreement. She expressed confidence that bipartisan support would lead to a bill the industry and America could be proud of.

Sen. Bill Hagerty, R-Tenn., echoed Lummis’ sentiments, expressing confidence in reaching a consensus quickly. He emphasized that the legislation aims to ensure innovation continues to thrive in the U.S. “I look forward to passing legislation that ensures this innovative technology flourishes in the United States for decades to come,” Hagerty said in a recent post.

The crypto industry continues to support the crypto bill despite the delay. Kraken co-CEO Arjun Sethi reaffirmed his commitment to working on market structure legislation, highlighting the importance of moving forward. “Walking away now would not preserve the status quo in practice,” Sethi said. “It would lock in uncertainty and leave American companies operating under ambiguity.”

The Digital Chamber CEO, Cody Carbone, also voiced his concern, stating that inaction is unacceptable. “We cannot afford to walk away from the table at a moment when clarity is within reach,” Carbone remarked in a statement on Thursday. Many crypto advocates emphasize the need for legislative clarity to avoid prolonged uncertainty.

Legislative Delays May Provide More Time for Consensus

Despite the setbacks, analysts believe the delay could prove beneficial in the long run. Benchmark analyst Mark Palmer noted that the postponement allows senators to build more bipartisan support. It provides lawmakers with additional time to refine the bill before it moves forward.

The Senate Agriculture Committee had initially scheduled a hearing on the bill for Thursday but rescheduled it for later in January. Both committees will need to reconcile their versions of the bill before a final vote in the Senate. Palmer noted that if successful, the bill could lead to the most substantial regulatory restructuring of U.S. financial markets in recent years.

While the delay offers more time for negotiations, gaining Democrat support remains a crucial challenge. TD Cowen’s Washington Research Group highlighted that addressing Coinbase’s concerns may complicate the process. They pointed out that the objections raised by Armstrong could be hard to resolve without altering provisions already negotiated with Democrats.

The importance of securing bipartisan support is clear. Most legislation requires 60 votes to pass in the Senate, which means Democrats’ votes will be crucial to the crypto bill’s success. Despite these hurdles, lawmakers remain committed to finalizing the bill before the upcoming midterm elections.

The post Senate Banking Committee Lawmakers Optimistic About Crypto Bill Progress appeared first on Blockonomi.

Market Opportunity
Sentio Protocol Logo
Sentio Protocol Price(SEN)
$0.00421
$0.00421$0.00421
-0.80%
USD
Sentio Protocol (SEN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23